balance equationreview2026-06-30
Difference 509069000 exceeds tolerance 29655896.000. Presentation or filing-vintage differences need review.
Revenue
$1.73B
Fiscal year ended 2026-06-30Operating income
Unavailable
Fiscal year ended 2026-06-30Free cash flow
Unavailable
Fiscal year ended 2026-06-30Ventas, Inc. (VTR) reported revenue of $1.73B for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Ventas, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Real Estate Investment Trusts.
Income
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.73B | $1.66B | $1.57B | $1.49B | $1.42B | $1.36B | $1.29B | $1.24B | $1.20B | $1.20B |
| Cost of revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross profit | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Operating income | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Net income | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 497.72M | shares 486.72M | Unavailable | shares 463.42M | shares 459.09M | shares 446.42M | Unavailable | shares 419.47M | shares 411.82M | shares 407.23M |
| Pretax income | $54.24M | $35.41M | $76.29M | $44.44M | $42.66M | $40.94M | -$508.00K | $19.10M | -$19.08M | -$7.50M |
| Income tax expense | -$25.62M | -$15.94M | -$1.12M | -$6.34M | $3.87M | -$10.56M | -$45.54M | $3.00M | $7.77M | -$3.00M |
| Diluted EPS | $0.14 | $0.11 | Unavailable | $0.14 | $0.15 | $0.10 | Unavailable | $0.05 | $0.05 | $-0.04 |
| Selling, general & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| General & administrative | $46.99M | $62.75M | $41.01M | $40.39M | $42.86M | $53.15M | $41.43M | $35.09M | $37.73M | $48.74M |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $198.96M | $183.61M | $741.07M | $188.62M | $614.20M | $182.34M | $897.85M | $1.10B | $557.08M | $632.44M |
| Total assets | $29.66B | $27.69B | $27.59B | $26.93B | $26.47B | $26.03B | $26.19B | $25.35B | $24.53B | $24.67B |
| Current assets | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Total liabilities | $14.44B | $14.11B | $14.63B | $14.15B | $14.55B | $14.17B | $15.05B | $15.19B | $14.55B | $14.93B |
| Current liabilities | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Total equity incl. NCI | $14.70B | $13.18B | $12.59B | $12.42B | $11.59B | $11.53B | $10.83B | $9.83B | $9.67B | $9.46B |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts receivable | $108.04M | $105.34M | $99.87M | $92.46M | $72.40M | $85.66M | $108.14M | Unavailable | Unavailable | Unavailable |
| Goodwill | $1.05B | $1.05B | $1.05B | $1.05B | $1.05B | $1.05B | $1.04B | $1.05B | $1.05B | $1.05B |
| Long-term debt | Unavailable | Unavailable | $13.01B | Unavailable | Unavailable | Unavailable | $13.52B | Unavailable | Unavailable | Unavailable |
| Accounts payable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Cash flow
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $556.55M | $394.61M | $471.66M | $378.58M | $475.34M | $321.14M | $373.64M | $353.66M | $335.87M | $266.45M |
| Capital expenditures | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Investing cash flow | -$1.95B | -$1.07B | -$428.72M | -$1.18B | -$204.42M | -$883.74M | -$1.54B | -$429.49M | -$266.80M | -$144.59M |
| Financing cash flow | $1.42B | $89.96M | $499.86M | $366.07M | $156.97M | -$149.14M | $956.20M | $624.45M | -$140.25M | $4.82M |
| Net change in cash | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Stock-based compensation | $5.31M | $24.84M | $6.32M | $5.90M | $7.68M | $18.83M | $4.65M | $4.27M | $5.79M | $16.28M |
| Common dividends paid | $253.35M | $230.19M | $225.68M | $218.39M | $216.96M | $199.02M | $188.96M | $186.21M | $182.31M | $182.85M |
| Common share repurchases | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Depreciation & amortization | $407.71M | $382.47M | $352.72M | $357.17M | $347.72M | $321.52M | $308.77M | $304.27M | $339.85M | $300.26M |
Derived
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Operating margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| FCF margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| SBC / revenue | 0.3% | 1.5% | 0.4% | 0.4% | 0.5% | 1.4% | 0.4% | 0.3% | 0.5% | 1.4% |
| Current ratio | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Revenue YoY growth | 21.7% | 22.0% | 21.7% | 20.4% | 18.3% | 13.2% | 10.5% | 7.5% | 8.6% | 11.4% |
| Net margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Long-term debt / equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | -47.2% | -45.0% | -1.5% | -14.3% | 9.1% | -25.8% | Unavailable | 15.7% | Unavailable | Unavailable |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open VTR in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-07-30View SEC filing
10-Q · Filed 2026-04-28View SEC filing
10-K · Filed 2026-02-06View SEC filing
10-Q · Filed 2025-10-30View SEC filing
10-Q · Filed 2025-07-31View SEC filing
10-Q · Filed 2025-05-01View SEC filing
Reconciliation checks needing review
16 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
balance equationreview2026-03-31
Difference 394578000 exceeds tolerance 27686545.000. Presentation or filing-vintage differences need review.
balance equationreview2025-12-31
Difference 375154000 exceeds tolerance 27591945.000. Presentation or filing-vintage differences need review.
balance equationreview2025-09-30
Difference 349951000 exceeds tolerance 26925704.000. Presentation or filing-vintage differences need review.
balance equationreview2025-06-30
Difference 328699000 exceeds tolerance 26474929.000. Presentation or filing-vintage differences need review.
balance equationreview2025-03-31
Difference 339729000 exceeds tolerance 26032295.000. Presentation or filing-vintage differences need review.
balance equationreview2024-12-31
Difference 310229000 exceeds tolerance 26186906.000. Presentation or filing-vintage differences need review.
balance equationreview2024-09-30
Difference 329688000 exceeds tolerance 25347189.000. Presentation or filing-vintage differences need review.
balance equationreview2024-06-30
Difference 311468000 exceeds tolerance 24530229.000. Presentation or filing-vintage differences need review.
balance equationreview2024-03-31
Difference 285044000 exceeds tolerance 24672586.000. Presentation or filing-vintage differences need review.
balance equationreview2023-12-31
Difference 302636000 exceeds tolerance 24725433.000. Presentation or filing-vintage differences need review.
balance equationreview2023-09-30
Difference 265374000 exceeds tolerance 24966609.000. Presentation or filing-vintage differences need review.